renzapride has been researched along with neostigmine in 1 studies
Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (neostigmine) | Trials (neostigmine) | Recent Studies (post-2010) (neostigmine) |
---|---|---|---|---|---|
70 | 12 | 2 | 5,020 | 454 | 637 |
Protein | Taxonomy | renzapride (IC50) | neostigmine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.54 | |
Cholinesterase | Homo sapiens (human) | 0.45 | |
Acetylcholinesterase | Homo sapiens (human) | 1.1 | |
Cholinesterase | Equus caballus (horse) | 2.93 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamato, T; Miyata, K; Nagakura, Y; Naitoh, Y; Yamano, M | 1 |
1 other study(ies) available for renzapride and neostigmine
Article | Year |
---|---|
Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.
Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Cisapride; Clonidine; Gastrointestinal Transit; Intestines; Male; Mice; Mice, Inbred C57BL; Neostigmine; Ondansetron; Piperidines; Receptors, Serotonin; Serotonin Antagonists | 1996 |